Moses R. Kamya
Expertise in
8
conditions

Moses R. Kamya

2C Nakasero Hill Road, 
Kampala, C, UG 
Expertise in
8
conditions
2C Nakasero Hill Road, 
Kampala, C, UG 

Overview

Moses Kamya practices in Kampala, Uganda. Mr. Kamya is highly rated in 8 conditions, according to our data. His top areas of expertise are Malaria, HIV/AIDS, Sepsis, and Hypertension.

His clinical research consists of co-authoring 607 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

2C Nakasero Hill Road, Kampala, C, Uganda
Other Locations
Mulago Hill, Kampala, C, Uganda

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention
Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
Enrollment Status: Completed
Publish Date: February 06, 2025
Intervention Type: Other
Study Phase: Not Applicable
Impact of Long-lasting Insecticidal Nets (LLINs) Treated With Pyrethroid Plus Pyriproxyfen vs LLINs Treated With Pyrethroid Plus Piperonyl Butoxide on Malaria Incidence in Uganda: a Cluster-randomised Trial
Impact of Long-lasting Insecticidal Nets (LLINs) Treated With Pyrethroid Plus Pyriproxyfen vs LLINs Treated With Pyrethroid Plus Piperonyl Butoxide on Malaria Incidence in Uganda: a Cluster-randomised Trial
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Behavioral, Other
Study Phase: Not Applicable
Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa
Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa
Enrollment Status: Completed
Publish Date: October 23, 2024
Intervention Type: Other
Study Phase: Not Applicable
Leveraging the HIV Platform for Hypertension Control in Uganda
Leveraging the HIV Platform for Hypertension Control in Uganda
Enrollment Status: Unknown
Publish Date: November 04, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
Impact of Housing Modifications Combined With Piperonyl Butoxide (PBO) Long-lasting Insecticidal Nets (LLINs) on the Malaria Burden in Uganda: a Cluster-randomised Trial
Impact of Housing Modifications Combined With Piperonyl Butoxide (PBO) Long-lasting Insecticidal Nets (LLINs) on the Malaria Burden in Uganda: a Cluster-randomised Trial
Enrollment Status: Unknown
Publish Date: August 04, 2022
Intervention Type: Other
Study Phase: Not Applicable
Sustainable East Africa Research in Community Health
Sustainable East Africa Research in Community Health
Enrollment Status: Completed
Publish Date: March 02, 2022
Intervention Type: Other
Study Phase: Not Applicable
Innovative Incentive Strategies for Sustainable HIV Testing and Antiretroviral Treatment
Innovative Incentive Strategies for Sustainable HIV Testing and Antiretroviral Treatment
Enrollment Status: Completed
Publish Date: February 24, 2022
Intervention Type: Other, Behavioral
Study Phase: Not Applicable
Optimizing HIV Viral Load Monitoring and Outcomes for High Risk Populations
Optimizing HIV Viral Load Monitoring and Outcomes for High Risk Populations
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

607 Total Publications

Sustained High Prevalence of Multiple Antimalarial Drug Resistance Markers in Uganda in 2023-24.
Sustained High Prevalence of Multiple Antimalarial Drug Resistance Markers in Uganda in 2023-24.
Journal: medRxiv : the preprint server for health sciences
Published: March 27, 2026

Frequently Asked Questions about Moses R. Kamya

Is Moses R. Kamya a top-rated expert for Malaria?

MediFind is an objective health platform that identifies experts based on real-world data. Moses R. Kamya is classified as an Elite expert for Malaria, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Moses R. Kamya participate in research or clinical trials?

Yes. Moses R. Kamya has published 607 articles and abstracts on conditions like Malaria. You can view a list of Moses R. Kamya's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kamya's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile